Proceedings/Aztreonam: new developments in the treatment of Gram-negative infections in the pediatric population, symposium, Chicago IL, November 17, 1988ARONOFF, S. C.The Pediatric infectious disease journal. 1989, Vol 8, Num 9, pp 99-132, issn 0891-3668, supplConference Proceedings

Outer membrane permeability in Pseudomonas cepacia: diminished porin content in a β-lactam-resistant mutant and in resistant cystic fibrosis isolatesARONOFF, S. C.Antimicrobial agents and chemotherapy. 1988, Vol 32, Num 11, pp 1636-1639, issn 0066-4804Article

Anaerobic meningitis in children : case report and review of the literatureLAW, D. A; ARONOFF, S. C.The Pediatric infectious disease journal. 1992, Vol 11, Num 11, pp 968-971, issn 0891-3668Article

Decreased baseline β-lactamase production and inducibility associated with increased piperacillin susceptibility of Pseudomonas cepacia isolated from children with cystic fibrosisCHIESA, C; LABROZZI, P. H; ARONOFF, S. C et al.Pediatric research. 1986, Vol 20, Num 11, pp 1174-1177, issn 0031-3998Article

The effect of sodium on amiloride-tobramycin synergy in Pseudomonas cepaciaCOHN, R. C; ARONOFF, S. C.The Journal of laboratory and clinical medicine. 1989, Vol 114, Num 6, pp 724-727, issn 0022-2143Article

Factors that influence the evolution of β-lactam resistance in β-lactamase-unducible strains of Enterobacter cloacae and Pseudomonas aeruginosaARONOFF, S. C; SHLAES, D. M.The Journal of infectious diseases. 1987, Vol 155, Num 5, pp 936-941, issn 0022-1899Article

Clinical presentation and management of Pseudomonas osteomyelitisELLIOTT, S. J; ARONOFF, S. C.Clinical pediatrics. 1985, Vol 24, Num 10, pp 566-570, issn 0009-9228Article

In-vitro activity of ciprofloxacin and other antibacterial agents against Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patientsKLINGER, J. D; ARONOFF, S. C.Journal of antimicrobial chemotherapy (Print). 1985, Vol 15, Num 6, pp 679-684, issn 0305-7453Article

Current concepts review: antimicrobial therapy of childhood skeletal infectionsSCOLES, P. V; ARONOFF, S. C.Journal of bone and joint surgery. American volume. 1984, Vol 66, Num 9, pp 1487-1492, issn 0021-9355Article

Evaluation of latamoxef as initial therapy of bone and joint infections in childhoodARONOFF, S. C; SCOLES, P. V; REED, M. D et al.Chemotherapy (Basel). 1984, Vol 30, Num 5, pp 337-344, issn 0009-3157Article

A double-blinded comparative study of sultamicillin and potassium penicillin V in the treatment of childhood streptococcal pharyngitisARONOFF, S. C; KLINGER, J. D; ÓBRIEN, C. A et al.Journal of antimicrobial chemotherapy (Print). 1984, Vol 14, Num 3, pp 261-265, issn 0305-7453Article

Ceftazidime as initial therapy for suspected bacterial infections in hospitalized pediatric patientsREED, M. D; ÓBRIEN, C. A; ARONOFF, S. C et al.Antimicrobial agents and chemotherapy. 1984, Vol 26, Num 3, pp 318-321, issn 0066-4804Article

The effect of alginate on the invasion of cystic fibrosis respiratory epithelial cells by clinical isolates of Pseudomonas aeruginosaMASSENGALE, A. R. D; QUINN, F. J; WILLIAMS, A et al.Experimental lung research. 2000, Vol 26, Num 3, pp 163-178, issn 0190-2148Article

Effects of pentoxifylline on sputum neutrophil elastase and pulmonary function in patients with cystic fibrosis : preliminary observationsARONOFF, S. C; QUINN, F. J; CARPENTER, L. S et al.The Journal of pediatrics. 1994, Vol 125, Num 6, pp 992-997, issn 0022-3476, 1Article

Longitudinal serum IgG responses to Pseudomonas cepacia surface antigens in cystic fibrosisARONOFF, S. C; QUINN, F. J; STERN, R. C et al.Pediatric pulmonology. 1991, Vol 11, Num 4, pp 289-293, issn 8755-6863Article

Comparative activities of the β-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonadsJACOBS, M. R; ARONOFF, S. C; JOHENNING, S et al.Journal of antimicrobial chemotherapy (Print). 1986, Vol 18, Num 2, pp 177-184, issn 0305-7453Article

Use of the paraffin wax baiting system for identification of Pseudomonas aeruginosa clinical isolatesMASSENGALE, A. R. D; OLLAR, R. A; GIORDANO, S. J et al.Diagnostic microbiology and infectious disease. 1999, Vol 35, Num 3, pp 177-183, issn 0732-8893Article

Comparative activities of the β-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined β-lactamase-producing aerobic gram-negative BacilliJACOBS, M. R; ARONOFF, S. C; JOHENNING, S et al.Antimicrobial agents and chemotherapy. 1986, Vol 29, Num 6, pp 980-985, issn 0066-4804Article

Pharmacokinetics and cerebrospinal fluid penetration of ceftazidime in children with meningitisBLUMER, J. L; ARONOFF, S. C; MYERS, C. M et al.Developmental pharmacology and therapeutics. 1985, Vol 8, Num 4, pp 219-231, issn 0379-8305Article

Pseudomonas aeruginosa as a primary pathogen in children with bacterial peritonitisARONOFF, S. C; OLSON, M. M; GAUDERER, M. W. L et al.Journal of pediatric surgery. 1987, Vol 22, Num 9, pp 861-864, issn 0022-3468Article

Comparison of the efficacy and safety of ceftriaxone to ampicillin/chloramphenicol in the treatment of childhood meningitisARONOFF, S. C; REED, M. D; ÓBRIEN, C. A et al.Journal of antimicrobial chemotherapy (Print). 1984, Vol 13, Num 2, pp 143-151, issn 0305-7453Article

Developmental pharmacokinetics of moxalactamREED, M. D; ARONOFF, S. C; MYERS, C. M et al.Antimicrobial agents and chemotherapy. 1983, Vol 24, Num 3, pp 383-387, issn 0066-4804Article